S13F (p.Ser13Phe) variant of KRT16 (Keratin, type I cytoskeletal 16)

S13F (p.Ser13Phe) in KRT16 (Keratin, type I cytoskeletal 16) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.62 / 1. The record also includes population frequency data and structural context.

S13F (p.Ser13Phe) variant details